News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Astorg Completes Acquisition of OPEN Health From Amulet Capital Partners
Tuesday, July 19, 2022Astorg and Amulet Capital Partners have finalized the acquisition of OPEN Health a global provider of scientific communications and market access services to the pharmaceutical industry OPEN Health established in operates in locations across six co...
Polpharma Biologics Announces EMA Acceptance of Marketing Authorization Application for Proposed Biosimilar Natalizumab
Friday, July 15, 2022Polpharma Biologics an international biotech company specializing in biosimilar development announced today that the European Medicines Agency EMA has officially accepted the Marketing Authorization Application MAA for biosimilar natalizumab which ai...
Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU
Thursday, July 14, 2022Relief Therapeutics Holding SA a biopharmaceutical company seeking to serve patients with rare metabolic and genetic diseases with unmet medical need today announced that its wholly owned subsidiary APR Applied Pharma Research SA APR has executed a d...
Nanoform and Pharmanovia to breathe new life into iconic medicines
Thursday, July 14, 2022Nanoform Finland Plc an innovative company specializing in nanoparticle medicine technology has announced a strategic partnership with Pharmanovia a rapidly expanding specialty pharmaceutical company with a portfolio of over branded drugs available...
Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product
Wednesday, July 13, 2022Provepharm a French company specialized in the development of pharmaceutical applications today announces that it has received FDA New Drug Approval for the marketing of BLUDIGO its indigo carmine injectable Indigotindisulfonate Sodium drug product B...
Saphetor Partners With PTC Therapeutics to Advance Awareness of Clinical Programs in Rare Diseases
Wednesday, July 13, 2022Saphetor a global precision medicine company and the creator of VarSome The Human Genomics Community and variant interpretation platform announced today a partnership with PTC Therapeutics International Limited The open genomics community VarSomecom...
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
Tuesday, July 12, 2022At the Euromar Conference Bruker announced three new customer orders for GHz systems which will incorporate novel compact GHz NMR magnets for structural biology applications and clinical research in singlestory laboratories The new Ascend Evo GHz...
Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill
Tuesday, July 12, 2022Perrigo Company plc a leading global provider of Consumer SelfCare Products today announced that HRA Pharma a Perrigo company has submitted its application to the United States Food and Drug Administration FDA for the firstever overthecounter OTC bir...
Sobi to license loncastuximab tesirine from ADC Therapeutics
Friday, July 08, 2022Sobi today announced an exclusive license agreement with ADC Therapeutics SA to develop and commercialise loncastuximab tesirine for use in haematology and other indications of large unmet medical need in Europe and most international markets Loncast...
Northwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, UK Facility
Thursday, July 07, 2022Northwest Biotherapeutics a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers today announced that an application for license of the manufacturing facility in Sawston UK for commercial manufacturing of cellu...
